Baxter
BAXApprovedBaxter International is a nearly century-old healthcare giant with a $8.3 billion valuation, focused on saving and sustaining lives through innovative medical devices and connected healthcare solutions. The company provides essential products across acute care, nutritional care, hospital care, surgical care, and respiratory health, serving healthcare providers in hospitals, physician offices, and home care settings. With operations in over 100 countries, Baxter is positioned at the forefront of connected healthcare delivery, addressing critical challenges like nursing shortages and care coordination through digitized data sharing and connected devices.
BAX · Stock Price
Historical price data
AI Company Overview
Baxter International is a nearly century-old healthcare giant with a $8.3 billion valuation, focused on saving and sustaining lives through innovative medical devices and connected healthcare solutions. The company provides essential products across acute care, nutritional care, hospital care, surgical care, and respiratory health, serving healthcare providers in hospitals, physician offices, and home care settings. With operations in over 100 countries, Baxter is positioned at the forefront of connected healthcare delivery, addressing critical challenges like nursing shortages and care coordination through digitized data sharing and connected devices.
Technology Platform
Connected healthcare solutions integrating medical devices with digital data sharing capabilities, focusing on infusion systems, remote monitoring, and clinical workflow optimization.
Pipeline Snapshot
132132 drugs in pipeline, 34 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| Ropivacaine 0.1% + Ropivacaine 0.4% | Relatively Healthy Volunteers | Approved |
| Sevoflurane + propofol + remifentanil | Intra-abdominal and Intrapelvic Surgery | Approved |
| Physioneal + Dianeal + Extraneal + Nutrineal | ESRD | Approved |
| Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution | Peritoneal Dialysis | Approved |
| Clinolipid + Intralipid | Essential Fatty Acid Deficiency (EFAD) | Approved |
FDA Approved Drugs
211Opportunities
Risk Factors
Competitive Landscape
Baxter competes with major players like Medtronic, Abbott, J&J, and Fresenius Medical Care, differentiating through its connected healthcare ecosystem and 90-year heritage. The company's integrated portfolio and global relationships provide competitive advantages over point-solution competitors in the evolving healthcare technology landscape.
Company Info
Trading
Contact
Therapeutic Areas
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile